Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Not applicable

Compression Ultrasonography in Non-high Probability of Deep Vein Thrombosis

NCT04917328 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2022-02-21
Last updated
2026-08-19

Condition(s) studied

Deep Vein Thrombosis

Investigational drug(s) / intervention(s)

compression ultrasound

compression ultrasound: performing a compression ultrasound

Study summary

Compression ultrasound is commonly used in emergency department. Accuracy to rule out deep vein thrombosis is excellent but lower then Ddimer assessment which is actually gold standard. With progress in formation of emergency physicians (EP), quality of material used, the investigators hypothesize that compression ultrasound can rule out deep vein thrombosis in case of non high probability, as standard care and DDimer assay.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * adult patient * Patient presenting to the emergency department with clinical suspicion of DVT (i.e. pain and/or lower extremity edema). * Patient with a non-high probability according to the modified Wells score, i.e. a score of 0 or 1 * Subject with a social health insurance plan * Subject able to understand the objectives and risks of the research and to give a signed and dated informed consent Exclusion Criteria: * Patient with suspected pulmonary embolism * Patient with a high probability of DVT * Impossible to perform a whole leg doppler ultrasound within 5 days * Pregnant or breast-feeding woman, on patient's declaration * Subject under court protection * Subject under guardianship or curatorship

Primary outcome measure(s)

  • Negative predictive value of compression ultrasound for diagnosis of deep vein thrombosis — The measurement is assessed during ED stay or in 5 days if DD is positive with no DVT in compression ultrasound

Trial sites (1)

FacilityCityRegionStatus
CHU Strasbourg Strasbourg France Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04917328 on ClinicalTrials.gov ↗ ← All trials in France